Bidirectional Mendelian randomization identifies differential causal associations between inflammatory cytokines and lung cancer subtypes.
Mendelian randomization study on relationships between inflammatory factors and lung cancer risk.
APA
Sun M, Gao X (2026). Bidirectional Mendelian randomization identifies differential causal associations between inflammatory cytokines and lung cancer subtypes.. Discover oncology, 17(1). https://doi.org/10.1007/s12672-026-04615-y
MLA
Sun M, et al.. "Bidirectional Mendelian randomization identifies differential causal associations between inflammatory cytokines and lung cancer subtypes.." Discover oncology, vol. 17, no. 1, 2026.
PMID
41665765
Abstract
Mendelian randomization study on relationships between inflammatory factors and lung cancer risk. Bidirectional two-sample Mendelian randomization approach, utilizing Genome-Wide Association Studies data for two primary lung cancer subtypes: non-small cell lung cancer and small cell lung cancer. The study elucidated the potential causal relationship between specific inflammatory factors and the risk of non-small cell lung cancer and small cell lung cancer.
같은 제1저자의 인용 많은 논문 (5)
- Clinical outcomes and immune contexture in SMARCA4-deficient gastric cancer patients.
- Prolonged survival with alectinib in a patient with advanced lung adenocarcinoma: a case report and literature review.
- Clarifying the survival impact of immunotherapy in HR+/HER2- metastatic breast cancer: methodological caveats from a real-world perspective - Letter to the Editor.
- Magnetic resonance-guided simultaneous multi-focal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study.
- Rethinking AI-based prediction of NAT response in breast cancer: toward mechanistic and subtype-aware modeling - Letter to the Editor.